Skip to main content
. 2011 Feb 4;7:49–57. doi: 10.2147/VHRM.S16925

Figure 1.

Figure 1

Incidences and Peto odds ratio (OR) for edema-related adverse events with vildagliptin 50 mg bid versus comparators (placebo and active comparators) in the all controlled studies (excluding open-label) safety population.

Abbreviation: Vilda, vildagliptin